Bridging the Past with the Future at Informatix Bio

What if autism didn’t take years and countless tests to diagnose? What if treatment didn’t feel like guess and check? And what if we could finally move beyond subjective questionnaires and start measuring real neurological patterns and changes down to the gene?

Welcome to Informatix Bio, where we believe the future of brain health will be defined by data-driven diagnostics and therapeutics. We’re building the first neurobiological platform to rethink how autism is diagnosed, understood, and treated. Not just for clinicians, but for the millions of families asking, why did it take so long to figure this out and how can this be treated more effectively?

From the Inside Out

Informatix Bio started with an unexpected realization that came later than desired. Growing up, the founder had textbook signs of what was then still called Asperger’s—repetitive speech and behaviors, intense focus on narrow interests, and difficulty in social settings—but back in the 90s, diagnosis was rare, and understanding was even rarer. There was also stigma against being diagnosed with what was then and still today considered a disability.

It wasn’t until a year ago—after autism became more visible in public conversations—that the founder picked up The Complete Guide to Asperger’s Syndrome by Tony Attwood. He remembers reading the first few chapters and feeling like someone had written a user manual for his life. Then, looking back at his own circle of friends—brilliant, awkward, often misunderstood—he realized many of them shared the same traits and most admitted to having been diagnosed. We are surrounded by autism, but still diagnosing it with a flashlight in the dark.

The Diagnosis Dilemma

Today, autism remains one of the most misdiagnosed, misunderstood conditions in the mental health landscape. Why?

• Subjectivity – Diagnosis depends on behavioral observation, not biology. That leads to bias, misclassification, or years of missed support.

• One-size-fits-all treatment – Once diagnosed, most people receive cookie-cutter interventions, with little consideration for genetics, environment, or brain structure.

• Lack of measurable outcomes – Success is usually judged by a therapist’s notes or a parent’s impression—not objective, biological feedback.

  
  

Medicine has evolved—but neurodiagnostics haven’t kept up. That’s the gap we’re bridging.

What We’re Building at Informatix Bio

Informatix Bio is a precision neurobiology platform. In plain English? We use data—not guesses—to diagnose and improve brain health.

Our vision includes:

🔬 Data-Driven Diagnosis

We aim to replace guesswork with biometric biomarkers—from eye-tracking to epigenetic signatures to real-time neuroimaging. Our future system will detect autism subtypes earlier and more accurately.

🧠 Personalized Interventions

Every brain is different. We’ll tailor treatment recommendations based on gene expression, brain structure, and environmental exposure. The goal isn’t just therapy—it’s targeted, biology-backed care.

📊 Real-Time Feedback Loops

We’ll measure pre- and post-treatment changes in gene expression and imaging data to fine-tune interventions—turning treatment from static plans into responsive systems.

Think of it as neurofeedback for the 21st century, powered by systems biology.

Why Now?

The technology finally exists to make this real and there's a huge push to uncover the impact of genetics on the brain, especially for autistic individuals.

We’re at the intersection of:

• Affordable whole-genome testing

• Consumer-grade eye-tracking and biometric sensors

• Epigenetic tools that can reflect real-world changes

• Advanced neuroimaging from partners like Kernel

  
  

What used to take $100,000 and a research lab can now be done for a fraction of the cost—and we intend to bring that power into every clinic, every home, and every parent’s hands.

The Future of Autism is Personalized

We’re not building just another healthtech tool. We’re building the first full-stack platform for brain diagnostics and treatment optimization.

We believe:

• Autism isn’t a mystery—it’s a measurable condition

• Diagnosis shouldn’t be delayed—it should be continuous

• Treatments should evolve as fast as the person does

  
  

And most importantly, every individual deserves a plan tailored to their brain and genes.

Join Us

Whether you’re a parent fighting for answers, a researcher tired of bad data, or an investor ready to back the next wave of neuro-innovation—we invite you to join us.

At Informatix Bio, we’re not just chasing better tools. We’re chasing a world where neurodivergent people are seen, supported, and finally understood through the power of data.

The brain is no longer a black box. Let’s open it together.